JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4951
Dogness International Corp
DOGZ
$15.7M
| $402K | ﹤0.01% |
8,842
+6,139
| +227% | +$276K |
2024 Q3
1 quarter
|
|
4952
Virco
VIRC
$103M
| $398K | ﹤0.01% |
38,828
+8,607
| +28% | +$121K |
2024 Q2
2 quarters
|
|
4953
Skillsoft
SKIL
$52M
| $398K | ﹤0.01% |
16,595
+16,458
| +12,013% | +$269K |
2020 Q1
19 quarters
|
|
4954
Invesco S&P Global Water Index ETF
CGW
$1.02B
| $396K | ﹤0.01% |
7,312
-2,642
| -27% | -$155K |
2022 Q4
8 quarters
|
|
4955
PUT
Syndax Pharmaceuticals
SNDX
$1.57B
| $395K | ﹤0.01% |
29,900
-4,300
| -13% | -$73.6K |
2024 Q1
3 quarters
|
|
4956
Compass Therapeutics
CMPX
$154M
| $395K | ﹤0.01% |
272,328
+227,864
| +512% | +$378K |
2023 Q1
7 quarters
|
|
4957
ALX Oncology
ALXO
$169M
| $394K | ﹤0.01% |
236,046
+195,112
| +477% | +$300K |
2020 Q3
17 quarters
|
|
|
NESR
4958
National Energy Services Reunited Corp
NESR
$2.49B
| $394K | ﹤0.01% |
+43,966
| New | +$389K |
2024 Q4
0 quarters
|
|
4959
D-Wave Quantum Inc
QBTS
$5.99B
| $393K | ﹤0.01% |
46,804
+8,001
| +21% | +$23.9K |
2024 Q2
2 quarters
|
|
|
URG
4960
Ur-Energy
URG
$418M
| $393K | ﹤0.01% |
341,669
+194,401
| +132% | +$240K |
2021 Q2
14 quarters
|
|
4961
Invesco MSCI Sustainable Future ETF
ERTH
$123M
| $392K | ﹤0.01% |
9,687
-1,639
| -14% | -$69.4K |
2021 Q4
12 quarters
|
|
|
EDR
4962
PUT
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $391K | ﹤0.01% |
12,500
| – | – |
2024 Q2
2 quarters
|
|
4963
LanzaTech
LNZA
$79.1M
| $390K | ﹤0.01% |
2,849
+1,494
| +110% | +$224K |
2023 Q2
6 quarters
|
|
|
KWY
4964
Kingsway Corp
KWY
$273M
| $390K | ﹤0.01% |
46,627
+18,095
| +63% | +$158K |
2023 Q1
7 quarters
|
|
4965
Northern Technologies International Corp
NTIC
$73.1M
| $389K | ﹤0.01% |
28,869
+17,149
| +146% | +$226K |
2023 Q3
5 quarters
|
|
4966
Xtrackers Low Beta High Yield Bond ETF
HYDW
$61.4M
| $387K | ﹤0.01% |
8,402
+22
| +0.3% | +$1.03K |
2023 Q3
5 quarters
|
|
4967
Sight Sciences
SGHT
$470M
| $387K | ﹤0.01% |
106,351
+36,691
| +53% | +$167K |
2021 Q3
13 quarters
|
|
4968
iShares MSCI Japan Value ETF
EWJV
$790M
| $386K | ﹤0.01% |
12,329
+10,844
| +730% | +$347K |
2024 Q1
3 quarters
|
|
4969
TAT Technologies
TATT
$457M
| $385K | ﹤0.01% |
14,993
+1,100
| +8% | +$23.4K |
2024 Q1
3 quarters
|
|
4970
Playtika
PLTK
$831M
| $382K | ﹤0.01% |
55,059
-25,091
| -31% | -$198K |
2021 Q1
15 quarters
|
|
4971
Invesco S&P MidCap Quality ETF
XMHQ
$5.41B
| $382K | ﹤0.01% |
3,877
-75,140
| -95% | -$7.78M |
2023 Q3
5 quarters
|
|
4972
Quest Resource Holding
QRHC
$28.9M
| $380K | ﹤0.01% |
58,532
+34,839
| +147% | +$256K |
2023 Q3
5 quarters
|
|
4973
Direxion Daily AAPL Bull 2X ETF
AAPU
$170M
| $380K | ﹤0.01% |
10,091
+4,166
| +70% | +$156K |
2024 Q2
2 quarters
|
|
|
ARTV
4974
Artiva Biotherapeutics
ARTV
$334M
| $379K | ﹤0.01% |
37,619
+26,893
| +251% | +$323K |
2024 Q3
1 quarter
|
|
|
SEZL
4975
Sezzle
SEZL
$3.62B
| $377K | ﹤0.01% |
27,882
+4,008
| +17% | +$189K |
2024 Q1
3 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.